News & Studies Recruiting
Resources
Research Participation | 800.965.9205; 608.263.5192; registry@waisman.wisc.edu
Participate in Research
The Waisman Center’s Research Registry links individuals and families to research projects at the Waisman Center. The Waisman Center maintains a confidential registry of families and individuals who would like to be contacted about upcoming research projects. Enrollment in the Research Registry does not obligate an individual or family to participate in any study.
Aging and Disability Resource Centers (ADRCs)
Call 844-WIS-ADRC (844-947-2372) for help finding your local ADRC or Tribal ADRS.
List of ADRCs and ADRS
ADRCs (aging and disability resource centers) provide Wisconsin residents with unbiased information related to aging or living with a disability. Our goal is to connect you with the right resources for your aging and disability needs. Each county in Wisconsin has a physical center where seniors and people with disabilities can come for information, assistance, and support. ADRCs are located in all 72 counties in Wisconsin. Most Tribal nations have dedicated Tribal aging and disability resource specialists (ADRS). Tribal ADRS help Tribal members get information in a way that is culturally responsive. They also help members access long-term care services.
Well Badger Resource Center | 800-642-7837; text: 608-360-9328; help@wellbadger.org; https://www.wellbadger.org/
When you have questions about health and social services, figuring out where to go when you need help can be overwhelming. We’re here to make it easier. Well Badger Resource Center is your one-stop connection to community, social, health, and government programs — a place to find what you need, when you need it.
Publications
-
Dembo, R. S., Hong, J., DaWalt, L. S., & Mailick, M. R. (2025). Age-related trajectories of health and cognition in mothers of children with developmental disabilities: Longitudinal findings from two independent studies. Social science & medicine (1982), 372, 117912. https://doi.org/10.1016/j.socscimed.2025.117912
-
Rea Reyes, R. E., Cody, K. A., Wilson, R. E., Zetterberg, H., Chin, N. A., Jonaitis, E. M., Bahr, M., Mandel, O., Wintlend, M., Bendlin, B. B., Okonkwo, O. C., Clark, L. R., Zammit, M., Asthana, S., Christian, B. T., Betthauser, T. J., Eisenmenger, L., Langhough, R. E., & Johnson, S. C. (2025). Visual read of [F-18]florquinitau PET that includes and extends beyond the mesial temporal lobe is associated with increased plasma pTau217 and cognitive decline in a cohort that is enriched with risk for Alzheimer’s disease. Alzheimer’s & Dementia, 21(2), e14406. https://doi.org/10.1002/alz.14406.
-
Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., Mapstone, M., Head, E., Christian, B. T., Hartley, S. L., & Alzheimer’s Biomarker Consortium–Down Syndrome (ABC–DS) (2024). Timeline to symptomatic Alzheimer’s disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study. The Lancet. Neurology, 23(12), 1214–1224. https://doi.org/10.1016/S1474-4422(24)00426-5
-
Xicota, L., Dang, L. T., Lee, A., Krinsky-McHale, S., Pang, D., Melilli, L., O’Bryant, S., Henson, R. L., Laymon, C., Lai, F., Rosas, H. D., Ances, B., Lott, I., Hom, C., Christian, B., Hartley, S., Zaman, S., Head, E., Mapstone, M., Jin, Z., … Alzheimer’s Biomarker Consortium – Down Syndrome (ABC-DS) (2024). The effects of mosaicism on biological and clinical markers of Alzheimer’s disease in adults with Down syndrome. EBioMedicine, 110, 105433. Advance online publication. https://doi.org/10.1016/j.ebiom.2024.105433
-
Cody, K. A., Langhough, R. E., Zammit, M. D., Clark, L., Chin, N., Christian, B. T., Betthauser, T. J., & Johnson, S. C. (2024). Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease. Brain, 147(6), 2144–2157. https://doi.org/10.1093/brain/awae116
-
Hillerstrom, H., Fisher, R., Janicki, M. P., Chicoine, B., Christian, B. T., Esbensen, A., Esralew, L., Fortea, J., Hartley, S., Hassenstab, J., Keller, S. M., Krinsky-McHale, S., Lai, F., Levin, J., McCarron, M., McDade, E., Rebillat, A. S., Rosas, H. D., Silverman, W., Strydom, A., … Zetterberg, H. (2024). Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. Alzheimer’s & dementia, 20(5), 3649–3656. https://doi.org/10.1002/alz.13778
-
Jonaitis, E. M., Hermann, B. P., Mueller, K. D., Clark, L. R., Du, L., Betthauser, T. J., Cody, K., Gleason, C. E., Christian, B. T., Asthana, S., Chappell, R. J., Chin, N. A., Johnson, S. C., & Langhough, R. E. (2024). Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts. Alzheimer’s & dementia, 20(5), 3305–3321. https://doi.org/10.1002/alz.13774
-
Piro-Gambetti, B., Schworer, E. K., Handen, B., Glukhovskaya, M., & Hartley, S. L. (2024). Does Employment Complexity Promote Healthy Cognitive Aging in Down Syndrome?. Journal of Intellectual Disabilities, 28(2), 499–513. https://doi.org/10.1177/17446295231169379
-
Wisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S. E., Price, J. C., Laymon, C. M., Krinsky-McHale, S. J., Lai, F., Rosas, H. D., Hartley, S. L., Zaman, S., Lott, I. T., Tudorascu, D., … Dominantly Inherited Alzheimer Network (2024). Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer’s disease: a cross-sectional study. The Lancet. Neurology, 23(5), 500–510. https://doi.org/10.1016/S1474-4422(24)00084-X
-
Schworer, E. K., Handen, B. L., Petersen, M., O’Bryant, S., Peven, J. C., Tudorascu, D. L., Lee, L., Krinsky-McHale, S. J., Hom, C. L., Clare, I. C. H., Christian, B. T., Schupf, N., Lee, J. H., Head, E., Mapstone, M., Lott, I., Ances, B. M., Zaman, S., Brickman, A. M., Lai, F., … Alzheimer Biomarker Consortium‐Down Syndrome (2024). Cognitive and functional performance and plasma biomarkers of early Alzheimer’s disease in Down syndrome. Alzheimer’s & dementia (Amsterdam, Netherlands), 16(2), e12582. https://doi.org/10.1002/dad2.12582
-
Gorijala, P., Aslam, M. M., Dang, L. T., Xicota, L., Fernandez, M. V., Sung, Y. J., Fan, K. H., Feingold, E., Surace, E. I., Chhatwal, J. P., Hom, C. L., Dominantly Inherited Alzheimer Network (DIAN), the Alzheimer’s Disease Neuroimaging Initiative (ADNI), NIA-LOAD family study, for the Alzheimer’s Biomarkers Consortium-Down Syndrome (ABC-DS) Investigators, Hartley, S. L., Hassenstab, J., Perrin, R. J., Mapstone, M., Zaman, S. H., Ances, B. M., Kamboh, M. I., … Cruchaga, C. (2024). Alzheimer’s polygenic risk scores are associated with cognitive phenotypes in Down syndrome. Alzheimer’s & dementia, 20(2), 1038–1049. https://doi.org/10.1002/alz.13506
-
Zammit, M. D., Betthauser, T. J., McVea, A. K., Laymon, C. M., Tudorascu, D. L., Johnson, S. C., Hartley, S. L., Converse, A. K., Minhas, D. S., Zaman, S. H., Ances, B. M., Stone, C. K., Mathis, C. A., Cohen, A. D., Klunk, W. E., Handen, B. L., Christian, B. T., & Alzheimer’s Biomarker Consortium – Down Syndrome (2024). Characterizing the emergence of amyloid and tau burden in Down syndrome. Alzheimer’s & dementia, 20(1), 388–398. https://doi.org/10.1002/alz.13444
-
Hartley, S. L., Handen, B., Tudorascu, D., Lee, L., Cohen, A., Schworer, E. K., Peven, J. C., Zammit, M., Klunk, W., Laymon, C., Minhas, D., Luo, W., Zaman, S., Ances, B., Preboske, G., Christian, B. T., & Alzheimer Biomarker Consortium – Down Syndrome (2024). AT(N) biomarker profiles and Alzheimer’s disease symptomology in Down syndrome. Alzheimer’s & dementia, 20(1), 366–375. https://doi.org/10.1002/alz.13446.
-
Stern, A. M., Van Pelt, K. L., Liu, L., Anderson, A. K., Ostaszewski, B., Mapstone, M., O’Bryant, S., Petersen, M. E., Christian, B. T., Handen, B. L., Selkoe, D. J., Schmitt, F., Head, E., & Alzheimer’s Biomarker Consortium-Down Syndrome (ABC-DS) investigators (2023). Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimer’s & dementia, 19(12), 5755–5764. https://doi.org/10.1002/alz.13382
-
Fleming, V., Helsel, B. C., Ptomey, L. T., Rosas, H. D., Handen, B., Laymon, C., Christian, B. T., Head, E., Mapstone, M., Lai, F., Krinsky-McHale, S., Zaman, S., Ances, B. M., Lee, J. H., Hartley, S. L., & Alzheimer’s Biomarker Consortium –Down Syndrome (ABC-DS) Consortium (2023). Weight Loss and Alzheimer’s Disease in Down Syndrome. Journal of Alzheimer’s disease : JAD, 91(3), 1215–1227. https://doi.org/10.3233/JAD-220865
-
Souder, D. C., McGregor, E. R., Rhoads, T. W., Clark, J. P., Porter, T. J., Eliceiri, K., Moore, D. L., Puglielli, L., & Anderson, R. M. (2023). Mitochondrial regulator PGC-1a in neuronal metabolism and brain aging. bioRxiv : the preprint server for biology, 2023.09.29.559526. https://doi.org/10.1101/2023.09.29.559526
-
Hartley, S. L., Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., Rosas, H. D., Klunk, W., … Alzheimer Biomarker Consortium-Down Syndrome (2023). Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome. Journal of Alzheimer’s Disease, 95(1), 213–225. https://doi.org/10.3233/JAD-230200
-
Krantz, M., Dalmacy, D., Bishop, L., Hyer, J. M., & Hand, B. N. (2023). Mortality rate and age of death among Medicare-enrolled autistic older adults. Research in Autism Spectrum Disorders, 100, 102077. https://doi.org/10.1016/j.rasd.2022.102077
-
Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S., Lai, F., Rosas, H. D., Lee, J. H., Silverman, W., … Dominantly Inherited Alzheimer Network (2023). Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet. Neurology, 22(1), 55–65. https://doi.org/10.1016/S1474-4422(22)00408-2
-
Moody, J. F., Dean, D. C., 3rd, Kecskemeti, S. R., Blennow, K., Zetterberg, H., Kollmorgen, G., Suridjan, I., Wild, N., Carlsson, C. M., Johnson, S. C., Alexander, A. L., & Bendlin, B. B. (2022). Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer’s disease pathology and neurodegeneration along the Alzheimer’s disease continuum. Alzheimer’s & dementia (Amsterdam, Netherlands), 14(1), e12381. https://doi.org/10.1002/dad2.12381
-
Betthauser, T. J., Bilgel, M., Koscik, R. L., Jedynak, B. M., An, Y., Kellett, K. A., Moghekar, A., Jonaitis, E. M., Stone, C. K., Engelman, C. D., Asthana, S., Christian, B. T., Wong, D. F., Albert, M., Resnick, S. M., Johnson, S. C., & Alzheimer’s Disease Neuroimaging Initiative (2022). Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain : a journal of neurology, 145(11), 4065–4079. https://doi.org/10.1093/brain/awac213
-
Krinsky-McHale, S. J., Hartley, S., Hom, C., Pulsifer, M., Clare, I., Handen, B. L., Lott, I. T., Schupf, N., Silverman, W., & Alzheimer’s Biomarker Consortium—Down Syndrome (ABC‐DS) Investigators (2022). A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome. Alzheimer’s & dementia (Amsterdam, Netherlands), 14(1), e12361. https://doi.org/10.1002/dad2.12361
-
Gupta, C., Xu, J., Jin, T., Khullar, S., Liu, X., Alatkar, S., Cheng, F., & Wang, D. (2022). Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease. PLoS Computational Biology, 18(7), e1010287. https://doi.org/10.1371/journal.pcbi.1010287
-
Wu, Y., West, N. R., Bhattacharyya, A., & Wiseman, F. K. (2022). Cell models for Down syndrome-Alzheimer’s disease research. Neuronal signaling, 6(1), NS20210054. https://doi.org/10.1042/NS20210054
-
Hartley, S. L., Handen, B. L., Tudorascu, D., Lee, L., Cohen, A., Piro-Gambetti, B., Zammit, M., Klunk, W., Laymon, C., Zaman, S., Ances, B. M., Sabbagh, M., & Christian, B. T. (2022). Role of tau deposition in early cognitive decline in Down syndrome. Alzheimer’s & dementia (Amsterdam, Netherlands), 14(1), e12256. https://doi.org/10.1002/dad2.12256
-
Lin, C. X., Li, H. D., Deng, C., Liu, W., Erhardt, S., Wu, F. X., Zhao, X. M., Guan, Y., Wang, J., Wang, D., Hu, B., & Wang, J. (2022). An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease. Briefings in bioinformatics, 23(1), bbab522. https://doi.org/10.1093/bib/bbab522
-
Fleming, V., Piro-Gambetti, B., Patrick, A., Zammit, M., Alexander, A., Christian, B. T., Handen, B., Cohen, A., Klunk, W., Laymon, C., Ances, B. M., Plante, D. T., Okonkwo, O., & Hartley, S. L. (2021). Physical activity and cognitive and imaging biomarkers of Alzheimer’s disease in down syndrome. Neurobiology of aging, 107, 118–127. https://doi.org/10.1016/j.neurobiolaging.2021.07.016
-
Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021). Alzheimer’s disease associated with Down syndrome: a genetic form of dementia. The Lancet. Neurology, 20(11), 930–942. https://doi.org/10.1016/S1474-4422(21)00245-3
-
Buckingham, W. R., Bishop, L., Hooper-Lane, C., Anderson, B., Wolfson, J., Shelton, S. V., & Kind, A. J. (2021). A systematic review of geographic indices of disadvantage with implications for older adults. JCI insight, 6(20), e141664. https://doi.org/10.1172/jci.insight.141664
-
Ennis, G. E., Kohli, A., Jonaitis, E. M., Betthauser, T. J., Oh, J. M., Taylor, C. E., Chin, N., Koscik, R. L., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2021). The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults. Neurobiology of aging, 105, 174–185. https://doi.org/10.1016/j.neurobiolaging.2021.04.028
-
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021). Corrigendum: Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease. Frontiers in aging neuroscience, 13, 742233. https://doi.org/10.3389/fnagi.2021.742233
-
Fagan, A. M., Henson, R. L., Li, Y., Boerwinkle, A. H., Xiong, C., Bateman, R. J., Goate, A., Ances, B. M., Doran, E., Christian, B. T., Lai, F., Rosas, H. D., Schupf, N., Krinsky-McHale, S., Silverman, W., Lee, J. H., Klunk, W. E., Handen, B. L., Allegri, R. F., Chhatwal, J. P., … Dominantly Inherited Alzheimer Network (2021). Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet. Neurology, 20(8), 615–626. https://doi.org/10.1016/S1474-4422(21)00139-3
-
Martinez, J. L., Zammit, M. D., West, N. R., Christian, B. T., & Bhattacharyya, A. (2021). Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease. Frontiers in aging neuroscience, 13, 703876. https://doi.org/10.3389/fnagi.2021.703876
-
Zammit, M. D., Tudorascu, D. L., Laymon, C. M., Hartley, S. L., Ellison, P. A., Zaman, S. H., Ances, B. M., Johnson, S. C., Stone, C. K., Sabbagh, M. N., Mathis, C. A., Klunk, W. E., Cohen, A. D., Handen, B. L., & Christian, B. T. (2021). Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome. NeuroImage. Clinical, 31, 102740. https://doi.org/10.1016/j.nicl.2021.102740
-
O’Bryant, S. E., Johnson, L. A., Barber, R. C., Braskie, M. N., Christian, B., Hall, J. R., Hazra, N., King, K., Kothapalli, D., Large, S., Mason, D., Matsiyevskiy, E., McColl, R., Nandy, R., Palmer, R., Petersen, M., Philips, N., Rissman, R. A., Shi, Y., Toga, A. W., … HABLE Study Team (2021). The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics. Alzheimer’s & dementia (Amsterdam, Netherlands), 13(1), e12202. https://doi.org/10.1002/dad2.12202
-
Mueller, K. D., Van Hulle, C. A., Koscik, R. L., Jonaitis, E., Peters, C. C., Betthauser, T. J., Christian, B., Chin, N., Hermann, B. P., & Johnson, S. (2021). Amyloid beta associations with connected speech in cognitively unimpaired adults. Alzheimer’s & dementia (Amsterdam, Netherlands), 13(1), e12203. https://doi.org/10.1002/dad2.12203
-
Jin, T., Rehani, P., Ying, M., Huang, J., Liu, S., Roussos, P., & Wang, D. (2021). scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks. Genome medicine, 13(1), 95. https://doi.org/10.1186/s13073-021-00908-9
-
Bin Imtiaz, M. K., Jaeger, B. N., Bottes, S., Machado, R. A. C., Vidmar, M., Moore, D. L., & Jessberger, S. (2021). Declining lamin B1 expression mediates age-dependent decreases of hippocampal stem cell activity. Cell stem cell, 28(5), 967–977.e8. https://doi.org/10.1016/j.stem.2021.01.015
-
Zammit, M. D., Tudorascu, D. L., Laymon, C. M., Hartley, S. L., Zaman, S. H., Ances, B. M., Johnson, S. C., Stone, C. K., Mathis, C. A., Klunk, W. E., Cohen, A. D., Handen, B. L., & Christian, B. T. (2021). PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome. NeuroImage, 228, 117728. https://doi.org/10.1016/j.neuroimage.2021.117728
-
Petersen, M. E., Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., Diana Rosas, H., Zaman, S., Wang, M. C., Tycko, B., … Alzheimer’s Biomarker Consortium –Down Syndrome (ABC-DS) (2021). Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome. Journal of Alzheimer’s disease : JAD, 79(2), 671–681. https://doi.org/10.3233/JAD-201167
-
Zammit, M. D., Laymon, C. M., Tudorascu, D. L., Hartley, S. L., Piro-Gambetti, B., Johnson, S. C., Stone, C. K., Mathis, C. A., Zaman, S. H., Klunk, W. E., Handen, B. L., Cohen, A. D., & Christian, B. T. (2021). Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer’s disease except for the putamen. Alzheimer’s & dementia (Amsterdam, Netherlands), 12(1), e12138. https://doi.org/10.1002/dad2.12138
-
Remer, J., Dean, D. C., 3rd, Chen, K., Reiman, R. A., Huentelman, M. J., Reiman, E. M., & Deoni, S. (2020). Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein ε4 allele. NeuroImage, 222, 117243. https://doi.org/10.1016/j.neuroimage.2020.117243
-
Mueller, K. D., Koscik, R. L., Du, L., Bruno, D., Jonaitis, E. M., Koscik, A. Z., Christian, B. T., Betthauser, T. J., Chin, N. A., Hermann, B. P., & Johnson, S. C. (2020). Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer’s disease. Cortex; a journal devoted to the study of the nervous system and behavior, 131, 137–150. https://doi.org/10.1016/j.cortex.2020.07.008
-
Hartley, S. L., Handen, B. L., Devenny, D., Tudorascu, D., Piro-Gambetti, B., Zammit, M. D., Laymon, C. M., Klunk, W. E., Zaman, S., Cohen, A., & Christian, B. T. (2020). Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome. Alzheimer’s & dementia (Amsterdam, Netherlands), 12(1), e12096. https://doi.org/10.1002/dad2.12096
-
Handen, B. L., Lott, I. T., Christian, B. T., Schupf, N., OBryant, S., Mapstone, M., Fagan, A. M., Lee, J. H., Tudorascu, D., Wang, M. C., Head, E., Klunk, W., Ances, B., Lai, F., Zaman, S., Krinsky-McHale, S., Brickman, A. M., Rosas, H. D., Cohen, A., Andrews, H., … Alzheimer’s Biomarker Consortium‐Down Syndrome (ABC‐DS) (2020). The Alzheimer’s Biomarker Consortium-Down Syndrome: Rationale and methodology. Alzheimer’s & dementia (Amsterdam, Netherlands), 12(1), e12065. https://doi.org/10.1002/dad2.12065
-
Henson, R. L., Doran, E., Christian, B. T., Handen, B. L., Klunk, W. E., Lai, F., Lee, J. H., Rosas, H. D., Schupf, N., Zaman, S. H., Lott, I. T., & Fagan, A. M. (2020). Cerebrospinal fluid biomarkers of Alzheimer’s disease in a cohort of adults with Down syndrome. Alzheimer’s & dementia (Amsterdam, Netherlands), 12(1), e12057. https://doi.org/10.1002/dad2.12057
-
Vogt NM, Hunt JF, Adluru N, Dean DC, Johnson SC, Asthana S, Yu JJ, Alexander AL, Bendlin BB. (2020). Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer’s Disease Dementia. Cerebral Cortex, 30(5):2948-2960. doi: 10.1093/cercor/bhz286.
-
Zammit MD, Laymon CM, Betthauser TJ, Cody KA, Tudorascu DL, Minhas DS, Sabbagh MN, Johnson SC, Zaman SH, Mathis CA, Klunk WE, Handen BL, Cohen AD, Christian BT. (2020). Amyloid accumulation in Down syndrome measured with amyloid load. Alzheimer’s & Dementia, 12(1):e12020. doi: 10.1002/dad2.12020. PMID: 32435686; PMCID: PMC7233422.
-
Mapstone M, Gross TJ, Macciardi F, Cheema AK, Petersen M, Head E, Handen BL, Klunk WE, Christian BT, Silverman W, Lott IT, Schupf N; Alzheimer’s Biomarkers Consortium–Down Syndrome (ABC‐DS) Investigators. (2020). Metabolic correlates of prevalent mild cognitive impairment and Alzheimer’s disease in adults with Down syndrome. Alzheimer’s & Dementia (Amst), 12(1):e12028. doi: 10.1002/dad2.12028. PMID: 32258359; PMCID: PMC7131985.
-
Homan KJ, Greenberg JS, Mailick MR. (2020). Generativity and Well-Being of Midlife and Aging Parents With Children With Developmental or Mental Health Problems. Research on Aging, 42(3-4):95-104. doi: 10.1177/0164027519884759. Epub 2019 Nov 7.
-
Rubenstein E, Hartley S, Bishop L. (2020). Epidemiology of Dementia and Alzheimer Disease in Individuals With Down Syndrome. JAMA Neurology, 1;77(2):262-264. doi: 10.1001/jamaneurol.2019.3666.
-
Betthauser TJ, Koscik RL, Jonaitis EM, Allison SL, Cody KA, Erickson CM, Rowley HA, Stone CK, Mueller KD, Clark LR, Carlsson CM, Chin NA, Asthana S, Christian BT, Johnson SC. (2020). Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Brain, 143(1):320-335. doi: 10.1093/brain/awz378.
-
Reddy, P. H., Swerdlow, R. H., Culberson, J., Kang, D., Mitchell, T. L., Smith, Q., Suneja, S., Ory, M. G., Kumar, S., Vijayan, M., Morsy, A., Arandia, G., Lawrence, J. J., George, E., Oliver, D., Pradeepkiran, J. A., Yin, X., Reddy, A. P., Manczak, M., Cengiz, P., … Oddo, S. (2019). Current Status of Healthy Aging and Dementia Research: A Symposium Summary. Journal of Alzheimer’s disease : JAD, 72(s1), S11–S35. https://doi.org/10.3233/JAD-190252
-
Mak E, Bickerton A, Padilla C, Walpert MJ, Annus T, Wilson LR, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Christian BT, Handen BL, Klunk WE, Menon DK, Nestor PJ, Zaman SH, Holland AJ. (2019). Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report. Alzheimers Dementia, 25;11:654-658. doi: 10.1016/j.dadm.2019.04.006.
-
Mihaila I, Handen BL, Christian BT, Lao PJ, Cody KA, Klunk WE, Tudorascu DL, Cohen AD, Okonkwo OC, Hartley SL. (2019). Leisure Activity, Brain β-amyloid, and Episodic Memory in Adults with Down Syndrome. Developmental Neurobiology, 79(7):738-749. doi: 10.1002/dneu.22677.
-
Hwang SJ, Adluru N, Kim WH, Johnson SC, Bendlin BB, Singh V. (2019). Associations Between Positron Emission Tomography Amyloid Pathology and Diffusion Tensor Imaging Brain Connectivity in Pre-Clinical Alzheimer’s Disease. Brain Connections, 9(2):162-173. doi: 10.1089/brain.2018.0590.
-
Clark LR, Koscik RL, Allison SL, Berman SE, Norton D, Carlsson CM, Betthauser TJ, Bendlin BB, Christian BT, Chin NA, Asthana S, Johnson SC. (2019). Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife. Alzheimers & Dementia, 15(3):418-428. doi: 10.1016/j.jalz.2018.09.008.
-
Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT. (2019). In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls. Journal of Nuclear Medicine, 60(1):93-99. doi: 10.2967/jnumed.118.209650.
-
Eichhorn JT, Kent RD, Austin D, Vorperian HK. (2018). Effects of Aging on Vocal Fundamental Frequency and Vowel Formants in Men and Women. Journal of Voice, 32(5):644.e1-644.e9. doi: 10.1016/j.jvoice.2017.08.003.
-
Lao PJ, Handen BL, Betthauser TJ, Cody KA, Cohen AD, Tudorascu DL, Stone CK, Price JC, Johnson SC, Klunk WE, Christian BT. (2018). Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation. Brain Imaging and Behavior, 13(2):345-353. doi: 10.1007/s11682-018-9888-y.
-
Tudorascu DL, Minhas DS, Lao PJ, Betthauser TJ, Yu Z, Laymon CM, Lopresti BJ, Mathis CA, Klunk WE, Handen BL, Christian BT, Cohen AD. (2018). The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimer’s and Dementia (Amst), 21;10:332-339. doi: 10.1016/j.dadm.2018.03.006.
-
Lao PJ, Handen BL, Betthauser TJ, Mihaila I, Hartley SL, Cohen AD, Tudorascu DL, Bulova PD, Lopresti BJ, Tumuluru RV, Murali D, Mathis CA, Barnhart TE, Stone CK, Price JC, Devenny DA, Johnson SC, Klunk WE, Christian BT. (2018). Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome. Journal of Alzheimers Disease, 61(2):631-644. doi: 10.3233/JAD-170720.
-
Mukherjee J, Lao PJ, Betthauser TJ, Samra GK, Pan ML, Patel IH, Liang C, Metherate R, Christian BT. (2018) Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. Comparative Neurology. 526(1): 80-95.
-
Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen Š, Gubert Olivé M, Shakirzyanova A, Leskelä S, Sarajärvi T, Viitanen M, Rinne JO, Hiltunen M, Haapasalo A, Giniatullin R, Tavi P, Zhang SC, Kanninen KM, Hämäläinen RH, Koistinaho J. (2017). PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer’s Disease. Stem Cell Reports, 9(6):1885-1897. doi: 10.1016/j.stemcr.2017.10.016.
-
Darst BF, Koscik RL, Racine AM, Oh JM, Krause RA, Carlsson CM, Zetterberg H, Blennow K, Christian BT, Bendlin BB, Okonkwo OC, Hogan KJ, Hermann BP, Sager MA, Asthana S, Johnson SC, Engelman CD. (2017) Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer’s Disease. Journal of Alzheimer’s Disease, 55(2):473-484.
-
Dougherty RJ, Schultz SA, Kirby TK, Boots EA, Oh JM, Edwards D, Gallagher CL, Carlsson CM, Bendlin BB, Asthana S, Sager MA, Hermann BP, Christian BT, Johnson SC, Cook DB, Okonkwo OC. (2017) Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer’s Disease. Journal of Alzheimer’s Disease. 58(4):1089-1097.
-
Hartley SL, Handen BL, Devenny D, Mihaila I, Hardison R, Lao PJ, Klunk WE, Bulova P, Johnson SC, Christian BT. (2017) Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome. Neurobiology of Aging. 58:68-76.
-
Shackman AJ, Fox AS, Oler JA, Shelton SE, Oakes TR, Davidson RJ, Kalin NH. (2017). Heightened extended amygdala metabolism following threat characterizes the early phenotypic risk to develop anxiety-related psychopathology. Molecular Psychiatry, 22(5):724-732. doi: 10.1038/mp.2016.132.
-
Boots EA, Schultz SA, Clark LR, Racine AM, Darst BF, Koscik RL, Carlsson CM, Gallagher CL, Hogan KJ, Bendlin BB, Asthana S, Sager MA, Hermann BP, Christian BT, Dubal DB, Engelman CD, Johnson SC, Okonkwo OC. (2017) BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer’s Prevention. Neurology. 88(22):2098-2106.
-
Dean DC 3rd, Hurley SA, Kecskemeti SR, O’Grady JP, Canda C, Davenport-Sis NJ, Carlsson CM, Zetterberg H, Blennow K, Asthana S, Sager MA, Johnson SC, Alexander AL, Bendlin BB. (2017) Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease. JAMA Neurology, 74(1):41-49. doi: 10.1001/jamaneurol.2016.3232.
-
Racine AM, Koscik RL, Nicholas CR, Clark LR, Okonkwo OC, Oh JM, Hillmer AT, Murali D, Barnhart TE, Betthauser TJ, Gallagher CL, Rowley HA, Dowling NM, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Carlsson CM, Christian BT, Johnson SC. (2016) Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation. Alzheimer’s & Dementia. 2:27-38.
-
Peng Y, Kim MJ, Hullinger R, O’Riordan KJ, Burger C, Pehar M, Puglielli L. (2016) Improved proteostasis in the secretory pathway rescues Alzheimer’s disease in the mouse. Brain. 139(Pt 3):937-52. doi: 10.1093/brain/awv385.
-
Clark LR, Racine AM, Koscik RL, Okonkwo OC, Engelman CD, Carlsson CM, Asthana S, Bendlin BB, Chappell R, Nicholas CR, Rowley HA, Oh JM, Hermann BP, Sager MA, Christian BT, Johnson SC. (2016) Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer’s Prevention study. Alzheimers & Dementia. 12(7):805-14. doi: 10.1016/j.jalz.2015.12.009.
-
Racine AM, Clark LR, Berman SE, Koscik RL, Mueller KD, Norton D, Nicholas CR, Blennow K, Zetterberg H, Jedynak B, Bilgel M, Carlsson CM, Christian BT, Asthana S, Johnson SC. (2016) Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer’s Disease. Journal of Alzheimer’s Disease. 18;54(4):1395-1408.
-
Song J, Mailick MR, Greenberg JS, Ryff CD, Lachman ME. (2016) Cognitive Aging in Parents of Children with Disabilities. Journals of Gerontology. Series B: Psychological Sciences. 71(5):821-30. doi: 10.1093/geronb/gbv015.
-
Peng Y, Puglielli L. (2016) Nϵ-lysine acetylation in the lumen of the endoplasmic reticulum: A way to regulate autophagy and maintain protein homeostasis in the secretory pathway. Autophagy. 2;12(6):1051-2. doi: 10.1080/15548627.2016.1164369.
-
Lao PJ, Betthauser TJ, Hillmer AT, Price JC, Klunk WE, Mihaila I, Higgins AT, Bulova PD, Hartley SL, Hardison R, Tumuluru RV, Murali D, Mathis CA, Cohen AD, Barnhart TE, Devenny DA, Mailick MR, Johnson SC, Handen BL, Christian BT. (2016) The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B. Alzheimer’s & Dementia. 12(4):380-390.
-
Schultz SA, Larson J, Oh J, Koscik R, Dowling MN, Gallagher CL, Carlsson CM, Rowley HA, Bendlin BB, Asthana S, Hermann BP, Johnson SC, Sager M, LaRue A, Okonkwo OC. (2015) Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer’s disease. Brain Imaging and Behavior, 9(4):729-36. doi: 10.1007/s11682-014-9329-5.
-
Darst BF, Koscik RL, Hermann BP, La Rue A, Sager MA, Johnson SC, Engelman CD. (2015) Heritability of cognitive traits among siblings with a parental history of Alzheimer’s disease. Journal of Alzheimer’s Disease. 1;45(4):1149-55. doi: 10.3233/JAD-142658.
-
Joshi G, Gan KA, Johnson DA, Johnson JA. (2015) Increased Alzheimer’s disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiology of Aging. 36(2):664-79. doi: 10.1016/j.neurobiolaging.2014.09.004.
-
Berman SE, Rivera-Rivera LA, Clark LR, Racine AM, Keevil JG, Bratzke LC, Carlsson CM, Bendlin BB, Rowley HA, Blennow K, Zetterberg H, Asthana S, Turski P, Johnson SC, Wieben O. (2015) Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer’s Disease. Alzheimers and Dementia (Amst). 1;1(4):420-428..
-
Kim WH, Adluru N, Chung MK, Okonkwo OC, Johnson SC, B Bendlin B, Singh V. (2015) Multi-resolution statistical analysis of brain connectivity graphs in preclinical Alzheimer’s disease. Neuroimage. 27;118:103-117. doi: 10.1016/j.neuroimage.2015.05.050.
-
Boots EA, Schultz SA, Oh JM, Larson J, Edwards D, Cook D, Koscik RL, Dowling MN, Gallagher CL, Carlsson CM, Rowley HA, Bendlin BB, LaRue A, Asthana S, Hermann BP, Sager MA, Johnson SC, Okonkwo OC. (2015) Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer’s disease. Brain Imaging and Behavior, 9(3):639-49. doi: 10.1007/s11682-014-9325-9.
-
Almeida RP, Schultz SA, Austin BP, Boots EA, Dowling NM, Gleason CE, Bendlin BB, Sager MA, Hermann BP, Zetterberg H, Carlsson CM, Johnson SC, Asthana S, Okonkwo OC. (2015) Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. JAMA Neurology, 72(6):699-706. doi: 10.1001/jamaneurol.2015.0098.
-
Mielke MM, Haughey NJ, Bandaru VV, Zetterberg H, Blennow K, Andreasson U, Johnson SC, Gleason CE, Blazel HM, Puglielli L, Sager MA, Asthana S, Carlsson CM. (2014) Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer’s disease. Neurobiology of Aging. 35(11):2486-94. doi: 10.1016/j.neurobiolaging.2014.05.019.
-
Piazza VE, Floyd FJ, Mailick MR, Greenberg JS. (2014) Coping and psychological health of aging parents of adult children with developmental disabilities. American Journal on Intellectual and Developmental Disabilities. 119(2):186-98.
-
Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, Hillmer AT, Wooten DW, Murali D, Barnhart TE, Hall LT, Racine AM, Klunk WE, Mathis CA, Bendlin BB, Gallagher CL, Carlsson CM, Rowley HA, Hermann BP, Dowling NM, Asthana S, Sager MA. (2014) Amyloid burden and neural function in people at risk for Alzheimer’s Disease. Neurobiology of Aging. 35(3):576-84.
-
Okonkwo OC, Oh JM, Koscik R, Jonaitis E, Cleary CA, Dowling NM, Bendlin BB, Larue A, Hermann BP, Barnhart TE, Murali D, Rowley HA, Carlsson CM, Gallagher CL, Asthana S, Sager MA, Christian BT, Johnson SC. (2014) Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer’s disease. Journal of the International Neuropsychological Society. 20(4):422-33.
-
Okonkwo OC, Xu G, Oh JM, Dowling NM, Carlsson CM, Gallagher CL, Birdsill AC, Palotti M, Wharton W, Hermann BP, Larue A, Bendlin BB, Rowley HA, Asthana S, Sager MA, Johnson SC. (2012) Cerebral Blood Flow is Diminished in Asymptomatic Middle-Aged Adults with Maternal History of Alzheimer’s Disease. Cerebral Cortex. Dec 12.
-
Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC. (2011) Effects of Atorvastatin on Cerebral Blood Flow in Middle-Aged Adults at Risk for Alzheimer’s Disease: A Pilot Study. Current Alzheimer Research. 2011 Nov 28. [Epub ahead of print].
-
Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V. (2011) Effects of hypoperfusion in Alzheimer’s disease. Journal of Alzheimers Disease. 26 Suppl 3:123-33.
-
Seltzer MM, Floyd F, Song J, Greenberg J, Hong J. (2011) Midlife and aging parents of adults with intellectual and developmental disabilities: impacts of lifelong parenting. American Journal on Intellectual and Developmental Disabilities. Nov;116(6):479-99.